sn
int64 | material
string | shape
string | coat_functional_group
string | synthesis_method
string | surface_charge
string | size_in_medium_nm
float64 | zeta_in_medium_mv
float64 | no_of_cells_cells_well
float64 | human_animal
string | cell_source
string | cell_tissue
string | cell_morphology
string | cell_age
string | time_hr
int64 | concentration
float64 | test
string | test_indicator
string | viability_%
float64 | doi
string | article_list
int64 | core_nm
float64 | hydrodynamic_nm
float64 | potential_mv
float64 | cell_type
string | journal_name
string | publisher
string | year
int64 | title
string | journal_is_oa
bool | is_oa
string | oa_status
string | pdf
string | access
int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
589 |
Au
|
spherical
| null |
Chemical Reduction
| null | null | null | 50,000 | null | null | null | null | null | 24 | 0.2 |
MTT
|
TetrazoliumSalt
| 91.134 |
10.1016/j.jphotobiol.2020.111778
| 11 | null | 46 | null |
MG-63
|
Journal of Photochemistry and Photobiology B: Biology
|
Elsevier BV
| 2,020 |
Size-dependent apoptotic activity of gold nanoparticles on osteosarcoma cells correlated with SERS signal
| false |
FALSE
|
closed
| 0 |
|
590 |
Au
|
spherical
| null |
Chemical Reduction
| null | null | null | 50,000 | null | null | null | null | null | 24 | 0.4 |
MTT
|
TetrazoliumSalt
| 87.223 |
10.1016/j.jphotobiol.2020.111778
| 11 | null | 46 | null |
MG-63
|
Journal of Photochemistry and Photobiology B: Biology
|
Elsevier BV
| 2,020 |
Size-dependent apoptotic activity of gold nanoparticles on osteosarcoma cells correlated with SERS signal
| false |
FALSE
|
closed
| 0 |
|
591 |
Au
|
spherical
| null |
Chemical Reduction
| null | null | null | 50,000 | null | null | null | null | null | 24 | 0.8 |
MTT
|
TetrazoliumSalt
| 47.849 |
10.1016/j.jphotobiol.2020.111778
| 11 | null | 46 | null |
MG-63
|
Journal of Photochemistry and Photobiology B: Biology
|
Elsevier BV
| 2,020 |
Size-dependent apoptotic activity of gold nanoparticles on osteosarcoma cells correlated with SERS signal
| false |
FALSE
|
closed
| 0 |
|
592 |
Au
|
spherical
| null |
Chemical Reduction
| null | null | null | 50,000 | null | null | null | null | null | 24 | 0.2 |
MTT
|
TetrazoliumSalt
| 91.134 |
10.1016/j.jphotobiol.2020.111778
| 11 | null | 60 | null |
MG-63
|
Journal of Photochemistry and Photobiology B: Biology
|
Elsevier BV
| 2,020 |
Size-dependent apoptotic activity of gold nanoparticles on osteosarcoma cells correlated with SERS signal
| false |
FALSE
|
closed
| 0 |
|
593 |
Au
|
spherical
| null |
Chemical Reduction
| null | null | null | 50,000 | null | null | null | null | null | 24 | 0.4 |
MTT
|
TetrazoliumSalt
| 87.353 |
10.1016/j.jphotobiol.2020.111778
| 11 | null | 60 | null |
MG-63
|
Journal of Photochemistry and Photobiology B: Biology
|
Elsevier BV
| 2,020 |
Size-dependent apoptotic activity of gold nanoparticles on osteosarcoma cells correlated with SERS signal
| false |
FALSE
|
closed
| 0 |
|
594 |
Au
|
spherical
| null |
Chemical Reduction
| null | null | null | 50,000 | null | null | null | null | null | 24 | 0.8 |
MTT
|
TetrazoliumSalt
| 56.845 |
10.1016/j.jphotobiol.2020.111778
| 11 | null | 60 | null |
MG-63
|
Journal of Photochemistry and Photobiology B: Biology
|
Elsevier BV
| 2,020 |
Size-dependent apoptotic activity of gold nanoparticles on osteosarcoma cells correlated with SERS signal
| false |
FALSE
|
closed
| 0 |
|
595 |
TiO2
|
Lentil
| null |
Commercial
| null | null | null | 160,000 |
H
|
Human
| null | null | null | 24 | 5 |
MTT
|
TetrazoliumSalt
| 99.234 |
10.1016/j.jtemb.2019.126413
| 12 | null | 5 | null |
SH-SY5Y
|
Journal of Trace Elements in Medicine and Biology
|
Elsevier BV
| 2,020 |
Neurotoxicity mediated by oxidative stress caused by titanium dioxide nanoparticles in human neuroblastoma (SH-SY5Y) cells
| false |
FALSE
|
closed
|
12_ferraro2019.pdf
| 0 |
596 |
TiO2
|
Lentil
| null |
Commercial
| null | null | null | 160,000 |
H
|
Human
| null | null | null | 24 | 10 |
MTT
|
TetrazoliumSalt
| 104.44 |
10.1016/j.jtemb.2019.126413
| 12 | null | 5 | null |
SH-SY5Y
|
Journal of Trace Elements in Medicine and Biology
|
Elsevier BV
| 2,020 |
Neurotoxicity mediated by oxidative stress caused by titanium dioxide nanoparticles in human neuroblastoma (SH-SY5Y) cells
| false |
FALSE
|
closed
|
12_ferraro2019.pdf
| 0 |
597 |
TiO2
|
Lentil
| null |
Commercial
| null | null | null | 160,000 |
H
|
Human
| null | null | null | 24 | 50 |
MTT
|
TetrazoliumSalt
| 136.91 |
10.1016/j.jtemb.2019.126413
| 12 | null | 5 | null |
SH-SY5Y
|
Journal of Trace Elements in Medicine and Biology
|
Elsevier BV
| 2,020 |
Neurotoxicity mediated by oxidative stress caused by titanium dioxide nanoparticles in human neuroblastoma (SH-SY5Y) cells
| false |
FALSE
|
closed
|
12_ferraro2019.pdf
| 0 |
598 |
TiO2
|
Lentil
| null |
Commercial
| null | null | null | 160,000 |
H
|
Human
| null | null | null | 24 | 100 |
MTT
|
TetrazoliumSalt
| 162.02 |
10.1016/j.jtemb.2019.126413
| 12 | null | 5 | null |
SH-SY5Y
|
Journal of Trace Elements in Medicine and Biology
|
Elsevier BV
| 2,020 |
Neurotoxicity mediated by oxidative stress caused by titanium dioxide nanoparticles in human neuroblastoma (SH-SY5Y) cells
| false |
FALSE
|
closed
|
12_ferraro2019.pdf
| 0 |
599 |
TiO2
|
Sphere
| null |
Sol-Gel Method
|
Negative
| null | null | null |
H
|
Human
| null | null | null | 24 | 1 |
MTT
|
TetrazoliumSalt
| 87.472 |
10.1016/j.procbio.2019.08.004
| 13 | null | 60 | -51.9 |
THP-1
|
Process Biochemistry
|
Elsevier BV
| 2,019 |
Cytotoxic and immunomodulatory effects of the low concentration of titanium dioxide nanoparticles (TiO2 NPs) on human cell lines - An in vitro study
| false |
FALSE
|
closed
|
13_madhubala2019.pdf
| 0 |
600 |
TiO2
|
Sphere
| null |
Sol-Gel Method
|
Negative
| null | null | null |
H
|
Human
| null | null | null | 24 | 10 |
MTT
|
TetrazoliumSalt
| 61.197 |
10.1016/j.procbio.2019.08.004
| 13 | null | 60 | -51.9 |
THP-1
|
Process Biochemistry
|
Elsevier BV
| 2,019 |
Cytotoxic and immunomodulatory effects of the low concentration of titanium dioxide nanoparticles (TiO2 NPs) on human cell lines - An in vitro study
| false |
FALSE
|
closed
|
13_madhubala2019.pdf
| 0 |
601 |
TiO2
|
Sphere
| null |
Sol-Gel Method
|
Negative
| null | null | null |
H
|
Human
| null | null | null | 24 | 20 |
MTT
|
TetrazoliumSalt
| 51.774 |
10.1016/j.procbio.2019.08.004
| 13 | null | 60 | -51.9 |
THP-1
|
Process Biochemistry
|
Elsevier BV
| 2,019 |
Cytotoxic and immunomodulatory effects of the low concentration of titanium dioxide nanoparticles (TiO2 NPs) on human cell lines - An in vitro study
| false |
FALSE
|
closed
|
13_madhubala2019.pdf
| 0 |
602 |
TiO2
|
Sphere
| null |
Sol-Gel Method
|
Negative
| null | null | null |
H
|
Human
| null | null | null | 24 | 50 |
MTT
|
TetrazoliumSalt
| 44.9 |
10.1016/j.procbio.2019.08.004
| 13 | null | 60 | -51.9 |
THP-1
|
Process Biochemistry
|
Elsevier BV
| 2,019 |
Cytotoxic and immunomodulatory effects of the low concentration of titanium dioxide nanoparticles (TiO2 NPs) on human cell lines - An in vitro study
| false |
FALSE
|
closed
|
13_madhubala2019.pdf
| 0 |
603 |
ZnO
|
Sph/Tri/Hex
| null |
Biosynthesis
| null | null | null | 100,000 |
H
|
Human
|
Blood
| null | null | 3 | 125 |
MTT
|
TetrazoliumSalt
| 95.027 |
10.1007/s00449-013-0982-7
| 14 | null | 75 | null |
Lymphocyte
|
Bioprocess and Biosystems Engineering
|
Springer Science and Business Media LLC
| 2,013 |
Biosynthesis and safety evaluation of ZnO nanoparticles
| false |
FALSE
|
closed
|
14_sarkar2013.pdf
| 0 |
604 |
ZnO
|
Sph/Tri/Hex
| null |
Biosynthesis
| null | null | null | 100,000 |
H
|
Human
|
Blood
| null | null | 3 | 250 |
MTT
|
TetrazoliumSalt
| 106.05 |
10.1007/s00449-013-0982-7
| 14 | null | 75 | null |
Lymphocyte
|
Bioprocess and Biosystems Engineering
|
Springer Science and Business Media LLC
| 2,013 |
Biosynthesis and safety evaluation of ZnO nanoparticles
| false |
FALSE
|
closed
|
14_sarkar2013.pdf
| 0 |
605 |
ZnO
|
Sph/Tri/Hex
| null |
Biosynthesis
| null | null | null | 100,000 |
H
|
Human
|
Blood
| null | null | 3 | 500 |
MTT
|
TetrazoliumSalt
| 74.757 |
10.1007/s00449-013-0982-7
| 14 | null | 75 | null |
Lymphocyte
|
Bioprocess and Biosystems Engineering
|
Springer Science and Business Media LLC
| 2,013 |
Biosynthesis and safety evaluation of ZnO nanoparticles
| false |
FALSE
|
closed
|
14_sarkar2013.pdf
| 0 |
606 |
ZnO
|
Sph/Tri/Hex
| null |
Biosynthesis
| null | null | null | 100,000 |
H
|
Human
|
Blood
| null | null | 3 | 1,000 |
MTT
|
TetrazoliumSalt
| 49.297 |
10.1007/s00449-013-0982-7
| 14 | null | 75 | null |
Lymphocyte
|
Bioprocess and Biosystems Engineering
|
Springer Science and Business Media LLC
| 2,013 |
Biosynthesis and safety evaluation of ZnO nanoparticles
| false |
FALSE
|
closed
|
14_sarkar2013.pdf
| 0 |
607 |
ZnO
|
Sph/Tri/Hex
| null |
Biosynthesis
| null | null | null | 100,000 |
H
|
Human
|
Blood
| null | null | 3 | 125 | null |
TrypanBlue
| 91.304 |
10.1007/s00449-013-0982-7
| 14 | null | 75 | null |
Lymphocyte
|
Bioprocess and Biosystems Engineering
|
Springer Science and Business Media LLC
| 2,013 |
Biosynthesis and safety evaluation of ZnO nanoparticles
| false |
FALSE
|
closed
|
14_sarkar2013.pdf
| 0 |
608 |
ZnO
|
Sph/Tri/Hex
| null |
Biosynthesis
| null | null | null | 100,000 |
H
|
Human
|
Blood
| null | null | 3 | 250 | null |
TrypanBlue
| 90.261 |
10.1007/s00449-013-0982-7
| 14 | null | 75 | null |
Lymphocyte
|
Bioprocess and Biosystems Engineering
|
Springer Science and Business Media LLC
| 2,013 |
Biosynthesis and safety evaluation of ZnO nanoparticles
| false |
FALSE
|
closed
|
14_sarkar2013.pdf
| 0 |
609 |
ZnO
|
Sph/Tri/Hex
| null |
Biosynthesis
| null | null | null | 100,000 |
H
|
Human
|
Blood
| null | null | 3 | 500 | null |
TrypanBlue
| 78.957 |
10.1007/s00449-013-0982-7
| 14 | null | 75 | null |
Lymphocyte
|
Bioprocess and Biosystems Engineering
|
Springer Science and Business Media LLC
| 2,013 |
Biosynthesis and safety evaluation of ZnO nanoparticles
| false |
FALSE
|
closed
|
14_sarkar2013.pdf
| 0 |
610 |
ZnO
|
Sph/Tri/Hex
| null |
Biosynthesis
| null | null | null | 100,000 |
H
|
Human
|
Blood
| null | null | 3 | 1,000 | null |
TrypanBlue
| 65.565 |
10.1007/s00449-013-0982-7
| 14 | null | 75 | null |
Lymphocyte
|
Bioprocess and Biosystems Engineering
|
Springer Science and Business Media LLC
| 2,013 |
Biosynthesis and safety evaluation of ZnO nanoparticles
| false |
FALSE
|
closed
|
14_sarkar2013.pdf
| 0 |
611 |
Fe3O4
|
Sphere
|
PEG
|
Solvothermal Process
| null | null | null | 100,000 |
H
|
Human
| null | null | null | 24 | 0.5 |
MTT
|
TetrazoliumSalt
| 88.907 |
10.1016/j.nano.2014.01.006
| 15 | null | 18.4 | null |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
612 |
Fe3O4
|
Sphere
|
PEG
|
Solvothermal Process
| null | null | null | 100,000 |
H
|
Human
| null | null | null | 24 | 1 |
MTT
|
TetrazoliumSalt
| 89.723 |
10.1016/j.nano.2014.01.006
| 15 | null | 18.4 | null |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
613 |
Fe3O4
|
Sphere
|
PEG
|
Solvothermal Process
| null | null | null | 100,000 |
H
|
Human
| null | null | null | 24 | 5 |
MTT
|
TetrazoliumSalt
| 93.312 |
10.1016/j.nano.2014.01.006
| 15 | null | 18.4 | null |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
614 |
Fe3O4
|
Sphere
|
PEG
|
Solvothermal Process
| null | null | null | 100,000 |
H
|
Human
| null | null | null | 24 | 10 |
MTT
|
TetrazoliumSalt
| 91.517 |
10.1016/j.nano.2014.01.006
| 15 | null | 18.4 | null |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
615 |
Fe3O4
|
Sphere
|
PEG
|
Solvothermal Process
| null | null | null | 100,000 |
H
|
Human
| null | null | null | 24 | 50 |
MTT
|
TetrazoliumSalt
| 80.914 |
10.1016/j.nano.2014.01.006
| 15 | null | 18.4 | null |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
616 |
Fe3O4
|
Sphere
|
PEG
|
Solvothermal Process
| null | null | null | 100,000 |
H
|
Human
| null | null | null | 24 | 100 |
MTT
|
TetrazoliumSalt
| 74.388 |
10.1016/j.nano.2014.01.006
| 15 | null | 18.4 | null |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
617 |
Fe3O4
|
Sphere
|
PEG-FA
|
Solvothermal Process
|
Negative
| 362.8 | -9.4 | 100,000 |
H
|
Human
| null | null | null | 24 | 0.5 |
MTT
|
TetrazoliumSalt
| 88.699 |
10.1016/j.nano.2014.01.006
| 15 | null | 326.5 | -23.5 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
618 |
Fe3O4
|
Sphere
|
PEG-FA
|
Solvothermal Process
|
Negative
| 362.8 | -9.4 | 100,000 |
H
|
Human
| null | null | null | 24 | 1 |
MTT
|
TetrazoliumSalt
| 87.158 |
10.1016/j.nano.2014.01.006
| 15 | null | 326.5 | -23.5 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
619 |
Fe3O4
|
Sphere
|
PEG-FA
|
Solvothermal Process
|
Negative
| 362.8 | -9.4 | 100,000 |
H
|
Human
| null | null | null | 24 | 5 |
MTT
|
TetrazoliumSalt
| 86.473 |
10.1016/j.nano.2014.01.006
| 15 | null | 326.5 | -23.5 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
620 |
Fe3O4
|
Sphere
|
PEG-FA
|
Solvothermal Process
|
Negative
| 362.8 | -9.4 | 100,000 |
H
|
Human
| null | null | null | 24 | 10 |
MTT
|
TetrazoliumSalt
| 90.925 |
10.1016/j.nano.2014.01.006
| 15 | null | 326.5 | -23.5 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
621 |
Fe3O4
|
Sphere
|
PEG-FA
|
Solvothermal Process
|
Negative
| 362.8 | -9.4 | 100,000 |
H
|
Human
| null | null | null | 24 | 50 |
MTT
|
TetrazoliumSalt
| 88.014 |
10.1016/j.nano.2014.01.006
| 15 | null | 326.5 | -23.5 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
622 |
Fe3O4
|
Sphere
|
PEG-FA
|
Solvothermal Process
|
Negative
| 362.8 | -9.4 | 100,000 |
H
|
Human
| null | null | null | 24 | 100 |
MTT
|
TetrazoliumSalt
| 85.616 |
10.1016/j.nano.2014.01.006
| 15 | null | 326.5 | -23.5 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
623 |
Fe3O4
|
Sphere
|
Silica-FA
|
Solvothermal Process
|
Negative
| 567.3 | -7.6 | 100,000 |
H
|
Human
| null | null | null | 24 | 0.5 |
MTT
|
TetrazoliumSalt
| 87.873 |
10.1016/j.nano.2014.01.006
| 15 | null | 274.1 | -27.7 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
624 |
Fe3O4
|
Sphere
|
Silica-FA
|
Solvothermal Process
|
Negative
| 567.3 | -7.6 | 100,000 |
H
|
Human
| null | null | null | 24 | 1 |
MTT
|
TetrazoliumSalt
| 86.455 |
10.1016/j.nano.2014.01.006
| 15 | null | 274.1 | -27.7 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
625 |
Fe3O4
|
Sphere
|
Silica-FA
|
Solvothermal Process
|
Negative
| 567.3 | -7.6 | 100,000 |
H
|
Human
| null | null | null | 24 | 5 |
MTT
|
TetrazoliumSalt
| 83.445 |
10.1016/j.nano.2014.01.006
| 15 | null | 274.1 | -27.7 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
626 |
Fe3O4
|
Sphere
|
Silica-FA
|
Solvothermal Process
|
Negative
| 567.3 | -7.6 | 100,000 |
H
|
Human
| null | null | null | 24 | 10 |
MTT
|
TetrazoliumSalt
| 91.639 |
10.1016/j.nano.2014.01.006
| 15 | null | 274.1 | -27.7 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
627 |
Fe3O4
|
Sphere
|
Silica-FA
|
Solvothermal Process
|
Negative
| 567.3 | -7.6 | 100,000 |
H
|
Human
| null | null | null | 24 | 50 |
MTT
|
TetrazoliumSalt
| 85.786 |
10.1016/j.nano.2014.01.006
| 15 | null | 274.1 | -27.7 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
628 |
Fe3O4
|
Sphere
|
Silica-FA
|
Solvothermal Process
|
Negative
| 567.3 | -7.6 | 100,000 |
H
|
Human
| null | null | null | 24 | 100 |
MTT
|
TetrazoliumSalt
| 84.114 |
10.1016/j.nano.2014.01.006
| 15 | null | 274.1 | -27.7 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
629 |
Fe3O4
|
Sphere
|
PEG
|
Solvothermal Process
| null | null | null | 100,000 |
H
|
Human
| null | null | null | 48 | 0.5 |
MTT
|
TetrazoliumSalt
| 105.22 |
10.1016/j.nano.2014.01.006
| 15 | null | 18.4 | null |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
630 |
Fe3O4
|
Sphere
|
PEG
|
Solvothermal Process
| null | null | null | 100,000 |
H
|
Human
| null | null | null | 48 | 1 |
MTT
|
TetrazoliumSalt
| 96.9 |
10.1016/j.nano.2014.01.006
| 15 | null | 18.4 | null |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
631 |
Fe3O4
|
Sphere
|
PEG
|
Solvothermal Process
| null | null | null | 100,000 |
H
|
Human
| null | null | null | 48 | 5 |
MTT
|
TetrazoliumSalt
| 94.29 |
10.1016/j.nano.2014.01.006
| 15 | null | 18.4 | null |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
632 |
Fe3O4
|
Sphere
|
PEG
|
Solvothermal Process
| null | null | null | 100,000 |
H
|
Human
| null | null | null | 48 | 10 |
MTT
|
TetrazoliumSalt
| 89.886 |
10.1016/j.nano.2014.01.006
| 15 | null | 18.4 | null |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
633 |
Fe3O4
|
Sphere
|
PEG
|
Solvothermal Process
| null | null | null | 100,000 |
H
|
Human
| null | null | null | 48 | 50 |
MTT
|
TetrazoliumSalt
| 86.949 |
10.1016/j.nano.2014.01.006
| 15 | null | 18.4 | null |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
634 |
Fe3O4
|
Sphere
|
PEG
|
Solvothermal Process
| null | null | null | 100,000 |
H
|
Human
| null | null | null | 48 | 100 |
MTT
|
TetrazoliumSalt
| 82.545 |
10.1016/j.nano.2014.01.006
| 15 | null | 18.4 | null |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
635 |
Fe3O4
|
Sphere
|
PEG-FA
|
Solvothermal Process
|
Negative
| 362.8 | -9.4 | 100,000 |
H
|
Human
| null | null | null | 48 | 0.5 |
MTT
|
TetrazoliumSalt
| 98.288 |
10.1016/j.nano.2014.01.006
| 15 | null | 326.5 | -23.5 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
636 |
Fe3O4
|
Sphere
|
PEG-FA
|
Solvothermal Process
|
Negative
| 362.8 | -9.4 | 100,000 |
H
|
Human
| null | null | null | 48 | 1 |
MTT
|
TetrazoliumSalt
| 99.144 |
10.1016/j.nano.2014.01.006
| 15 | null | 326.5 | -23.5 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
637 |
Fe3O4
|
Sphere
|
PEG-FA
|
Solvothermal Process
|
Negative
| 362.8 | -9.4 | 100,000 |
H
|
Human
| null | null | null | 48 | 5 |
MTT
|
TetrazoliumSalt
| 93.151 |
10.1016/j.nano.2014.01.006
| 15 | null | 326.5 | -23.5 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
638 |
Fe3O4
|
Sphere
|
PEG-FA
|
Solvothermal Process
|
Negative
| 362.8 | -9.4 | 100,000 |
H
|
Human
| null | null | null | 48 | 10 |
MTT
|
TetrazoliumSalt
| 92.979 |
10.1016/j.nano.2014.01.006
| 15 | null | 326.5 | -23.5 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
639 |
Fe3O4
|
Sphere
|
PEG-FA
|
Solvothermal Process
|
Negative
| 362.8 | -9.4 | 100,000 |
H
|
Human
| null | null | null | 48 | 50 |
MTT
|
TetrazoliumSalt
| 88.87 |
10.1016/j.nano.2014.01.006
| 15 | null | 326.5 | -23.5 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
640 |
Fe3O4
|
Sphere
|
PEG-FA
|
Solvothermal Process
|
Negative
| 362.8 | -9.4 | 100,000 |
H
|
Human
| null | null | null | 48 | 100 |
MTT
|
TetrazoliumSalt
| 86.473 |
10.1016/j.nano.2014.01.006
| 15 | null | 326.5 | -23.5 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
641 |
Fe3O4
|
Sphere
|
Silica-FA
|
Solvothermal Process
|
Negative
| 567.3 | -7.6 | 100,000 |
H
|
Human
| null | null | null | 48 | 0.5 |
MTT
|
TetrazoliumSalt
| 93.144 |
10.1016/j.nano.2014.01.006
| 15 | null | 274.1 | -27.7 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
642 |
Fe3O4
|
Sphere
|
Silica-FA
|
Solvothermal Process
|
Negative
| 567.3 | -7.6 | 100,000 |
H
|
Human
| null | null | null | 48 | 1 |
MTT
|
TetrazoliumSalt
| 87.793 |
10.1016/j.nano.2014.01.006
| 15 | null | 274.1 | -27.7 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
643 |
Fe3O4
|
Sphere
|
Silica-FA
|
Solvothermal Process
|
Negative
| 567.3 | -7.6 | 100,000 |
H
|
Human
| null | null | null | 48 | 5 |
MTT
|
TetrazoliumSalt
| 88.629 |
10.1016/j.nano.2014.01.006
| 15 | null | 274.1 | -27.7 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
644 |
Fe3O4
|
Sphere
|
Silica-FA
|
Solvothermal Process
|
Negative
| 567.3 | -7.6 | 100,000 |
H
|
Human
| null | null | null | 48 | 10 |
MTT
|
TetrazoliumSalt
| 90.301 |
10.1016/j.nano.2014.01.006
| 15 | null | 274.1 | -27.7 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
645 |
Fe3O4
|
Sphere
|
Silica-FA
|
Solvothermal Process
|
Negative
| 567.3 | -7.6 | 100,000 |
H
|
Human
| null | null | null | 48 | 50 |
MTT
|
TetrazoliumSalt
| 85.786 |
10.1016/j.nano.2014.01.006
| 15 | null | 274.1 | -27.7 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
646 |
Fe3O4
|
Sphere
|
Silica-FA
|
Solvothermal Process
|
Negative
| 567.3 | -7.6 | 100,000 |
H
|
Human
| null | null | null | 48 | 100 |
MTT
|
TetrazoliumSalt
| 83.445 |
10.1016/j.nano.2014.01.006
| 15 | null | 274.1 | -27.7 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
647 |
Fe3O4
|
Sphere
|
PEG-FA
|
Solvothermal Process
|
Negative
| 362.8 | -9.4 | 100,000 |
H
|
Human
| null | null | null | 24 | 0.5 |
LDH
|
LDHrelease
| 96.743 |
10.1016/j.nano.2014.01.006
| 15 | null | 326.5 | -23.5 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
648 |
Fe3O4
|
Sphere
|
PEG-FA
|
Solvothermal Process
|
Negative
| 362.8 | -9.4 | 100,000 |
H
|
Human
| null | null | null | 24 | 1 |
LDH
|
LDHrelease
| 83.225 |
10.1016/j.nano.2014.01.006
| 15 | null | 326.5 | -23.5 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
649 |
Fe3O4
|
Sphere
|
PEG-FA
|
Solvothermal Process
|
Negative
| 362.8 | -9.4 | 100,000 |
H
|
Human
| null | null | null | 24 | 5 |
LDH
|
LDHrelease
| 82.573 |
10.1016/j.nano.2014.01.006
| 15 | null | 326.5 | -23.5 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
650 |
Fe3O4
|
Sphere
|
PEG-FA
|
Solvothermal Process
|
Negative
| 362.8 | -9.4 | 100,000 |
H
|
Human
| null | null | null | 24 | 10 |
LDH
|
LDHrelease
| 80.945 |
10.1016/j.nano.2014.01.006
| 15 | null | 326.5 | -23.5 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
651 |
Fe3O4
|
Sphere
|
PEG-FA
|
Solvothermal Process
|
Negative
| 362.8 | -9.4 | 100,000 |
H
|
Human
| null | null | null | 24 | 50 |
LDH
|
LDHrelease
| 80.945 |
10.1016/j.nano.2014.01.006
| 15 | null | 326.5 | -23.5 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
652 |
Fe3O4
|
Sphere
|
PEG-FA
|
Solvothermal Process
|
Negative
| 362.8 | -9.4 | 100,000 |
H
|
Human
| null | null | null | 24 | 100 |
LDH
|
LDHrelease
| 79.316 |
10.1016/j.nano.2014.01.006
| 15 | null | 326.5 | -23.5 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
653 |
Fe3O4
|
Sphere
|
Silica-FA
|
Solvothermal Process
|
Negative
| 567.3 | -7.6 | 100,000 |
H
|
Human
| null | null | null | 24 | 0.5 |
LDH
|
LDHrelease
| 96.743 |
10.1016/j.nano.2014.01.006
| 15 | null | 274.1 | -27.7 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
654 |
Fe3O4
|
Sphere
|
Silica-FA
|
Solvothermal Process
|
Negative
| 567.3 | -7.6 | 100,000 |
H
|
Human
| null | null | null | 24 | 1 |
LDH
|
LDHrelease
| 82.573 |
10.1016/j.nano.2014.01.006
| 15 | null | 274.1 | -27.7 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
655 |
Fe3O4
|
Sphere
|
Silica-FA
|
Solvothermal Process
|
Negative
| 567.3 | -7.6 | 100,000 |
H
|
Human
| null | null | null | 24 | 5 |
LDH
|
LDHrelease
| 76.873 |
10.1016/j.nano.2014.01.006
| 15 | null | 274.1 | -27.7 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
656 |
Fe3O4
|
Sphere
|
Silica-FA
|
Solvothermal Process
|
Negative
| 567.3 | -7.6 | 100,000 |
H
|
Human
| null | null | null | 24 | 10 |
LDH
|
LDHrelease
| 76.873 |
10.1016/j.nano.2014.01.006
| 15 | null | 274.1 | -27.7 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
657 |
Fe3O4
|
Sphere
|
Silica-FA
|
Solvothermal Process
|
Negative
| 567.3 | -7.6 | 100,000 |
H
|
Human
| null | null | null | 24 | 50 |
LDH
|
LDHrelease
| 91.205 |
10.1016/j.nano.2014.01.006
| 15 | null | 274.1 | -27.7 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
658 |
Fe3O4
|
Sphere
|
Silica-FA
|
Solvothermal Process
|
Negative
| 567.3 | -7.6 | 100,000 |
H
|
Human
| null | null | null | 24 | 100 |
LDH
|
LDHrelease
| 91.205 |
10.1016/j.nano.2014.01.006
| 15 | null | 274.1 | -27.7 |
SKOV-3
|
Nanomedicine: Nanotechnology, Biology and Medicine
|
Elsevier BV
| 2,014 |
Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum
| false |
FALSE
|
closed
|
15_krais2014.pdf
| 0 |
659 |
Au
|
Rod
| null |
Commercial
| null | null | null | 3,000 |
A
|
Mouse
|
Embryo
|
Fibroblast
|
Embryonic
| 72 | 0.036 |
MTS
|
TetrazoliumSalt
| 80.385 |
10.1016/j.jhazmat.2013.11.031
| 16 | null | null | null |
NIH3T3
|
Journal of Hazardous Materials
|
Elsevier BV
| 2,014 |
Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines
| false |
FALSE
|
closed
|
16_chueh2014.pdf
| 0 |
660 |
Au
|
Rod
| null |
Commercial
| null | null | null | 3,000 |
A
|
Mouse
|
Embryo
|
Fibroblast
|
Embryonic
| 72 | 0.72 |
MTS
|
TetrazoliumSalt
| 72.957 |
10.1016/j.jhazmat.2013.11.031
| 16 | null | null | null |
NIH3T3
|
Journal of Hazardous Materials
|
Elsevier BV
| 2,014 |
Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines
| false |
FALSE
|
closed
|
16_chueh2014.pdf
| 0 |
661 |
Au
|
Rod
| null |
Commercial
| null | null | null | 3,000 |
A
|
Mouse
|
Embryo
|
Fibroblast
|
Embryonic
| 72 | 0.18 |
MTS
|
TetrazoliumSalt
| 56.616 |
10.1016/j.jhazmat.2013.11.031
| 16 | null | null | null |
NIH3T3
|
Journal of Hazardous Materials
|
Elsevier BV
| 2,014 |
Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines
| false |
FALSE
|
closed
|
16_chueh2014.pdf
| 0 |
662 |
Au
|
Rod
| null |
Commercial
| null | null | null | 3,000 |
A
|
Mouse
|
Embryo
|
Fibroblast
|
Embryonic
| 72 | 0.36 |
MTS
|
TetrazoliumSalt
| 49.684 |
10.1016/j.jhazmat.2013.11.031
| 16 | null | null | null |
NIH3T3
|
Journal of Hazardous Materials
|
Elsevier BV
| 2,014 |
Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines
| false |
FALSE
|
closed
|
16_chueh2014.pdf
| 0 |
663 |
Au
|
Rod
| null |
Commercial
| null | null | null | 3,000 |
A
|
Mouse
|
Embryo
|
Fibroblast
|
Embryonic
| 72 | 0.72 |
MTS
|
TetrazoliumSalt
| 42.256 |
10.1016/j.jhazmat.2013.11.031
| 16 | null | null | null |
NIH3T3
|
Journal of Hazardous Materials
|
Elsevier BV
| 2,014 |
Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines
| false |
FALSE
|
closed
|
16_chueh2014.pdf
| 0 |
664 |
Au
|
Rod
| null |
Commercial
| null | null | null | 3,000 |
A
|
Mouse
|
Embryo
|
Fibroblast
|
Embryonic
| 72 | 1 |
MTS
|
TetrazoliumSalt
| 42.586 |
10.1016/j.jhazmat.2013.11.031
| 16 | null | null | null |
NIH3T3
|
Journal of Hazardous Materials
|
Elsevier BV
| 2,014 |
Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines
| false |
FALSE
|
closed
|
16_chueh2014.pdf
| 0 |
665 |
Au
|
Rod
| null |
Commercial
| null | null | null | 3,000 |
A
|
Porcine
|
Kidney
|
Epithelial
| null | 72 | 0.36 |
MTS
|
TetrazoliumSalt
| 108.98 |
10.1016/j.jhazmat.2013.11.031
| 16 | null | null | null |
PK-15
|
Journal of Hazardous Materials
|
Elsevier BV
| 2,014 |
Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines
| false |
FALSE
|
closed
|
16_chueh2014.pdf
| 0 |
666 |
Au
|
Rod
| null |
Commercial
| null | null | null | 3,000 |
A
|
Porcine
|
Kidney
|
Epithelial
| null | 72 | 0.72 |
MTS
|
TetrazoliumSalt
| 106.23 |
10.1016/j.jhazmat.2013.11.031
| 16 | null | null | null |
PK-15
|
Journal of Hazardous Materials
|
Elsevier BV
| 2,014 |
Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines
| false |
FALSE
|
closed
|
16_chueh2014.pdf
| 0 |
667 |
Au
|
Rod
| null |
Commercial
| null | null | null | 3,000 |
A
|
Porcine
|
Kidney
|
Epithelial
| null | 72 | 0.18 |
MTS
|
TetrazoliumSalt
| 102.5 |
10.1016/j.jhazmat.2013.11.031
| 16 | null | null | null |
PK-15
|
Journal of Hazardous Materials
|
Elsevier BV
| 2,014 |
Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines
| false |
FALSE
|
closed
|
16_chueh2014.pdf
| 0 |
668 |
Au
|
Rod
| null |
Commercial
| null | null | null | 3,000 |
A
|
Porcine
|
Kidney
|
Epithelial
| null | 72 | 0.36 |
MTS
|
TetrazoliumSalt
| 90.126 |
10.1016/j.jhazmat.2013.11.031
| 16 | null | null | null |
PK-15
|
Journal of Hazardous Materials
|
Elsevier BV
| 2,014 |
Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines
| false |
FALSE
|
closed
|
16_chueh2014.pdf
| 0 |
669 |
Au
|
Rod
| null |
Commercial
| null | null | null | 3,000 |
A
|
Porcine
|
Kidney
|
Epithelial
| null | 72 | 0.72 |
MTS
|
TetrazoliumSalt
| 63.619 |
10.1016/j.jhazmat.2013.11.031
| 16 | null | null | null |
PK-15
|
Journal of Hazardous Materials
|
Elsevier BV
| 2,014 |
Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines
| false |
FALSE
|
closed
|
16_chueh2014.pdf
| 0 |
670 |
Au
|
Rod
| null |
Commercial
| null | null | null | 3,000 |
A
|
Porcine
|
Kidney
|
Epithelial
| null | 72 | 1 |
MTS
|
TetrazoliumSalt
| 47.518 |
10.1016/j.jhazmat.2013.11.031
| 16 | null | null | null |
PK-15
|
Journal of Hazardous Materials
|
Elsevier BV
| 2,014 |
Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines
| false |
FALSE
|
closed
|
16_chueh2014.pdf
| 0 |
671 |
Au
|
Rod
| null |
Commercial
| null | null | null | 3,000 |
A
|
Monkey
|
Kidney
|
Epithelial
| null | 72 | 0.036 |
MTS
|
TetrazoliumSalt
| 101.35 |
10.1016/j.jhazmat.2013.11.031
| 16 | null | null | null |
VERO
|
Journal of Hazardous Materials
|
Elsevier BV
| 2,014 |
Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines
| false |
FALSE
|
closed
|
16_chueh2014.pdf
| 0 |
672 |
Au
|
Rod
| null |
Commercial
| null | null | null | 3,000 |
A
|
Monkey
|
Kidney
|
Epithelial
| null | 72 | 0.072 |
MTS
|
TetrazoliumSalt
| 91.689 |
10.1016/j.jhazmat.2013.11.031
| 16 | null | null | null |
VERO
|
Journal of Hazardous Materials
|
Elsevier BV
| 2,014 |
Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines
| false |
FALSE
|
closed
|
16_chueh2014.pdf
| 0 |
673 |
Au
|
Rod
| null |
Commercial
| null | null | null | 3,000 |
A
|
Monkey
|
Kidney
|
Epithelial
| null | 72 | 0.18 |
MTS
|
TetrazoliumSalt
| 67.636 |
10.1016/j.jhazmat.2013.11.031
| 16 | null | null | null |
VERO
|
Journal of Hazardous Materials
|
Elsevier BV
| 2,014 |
Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines
| false |
FALSE
|
closed
|
16_chueh2014.pdf
| 0 |
674 |
Au
|
Rod
| null |
Commercial
| null | null | null | 3,000 |
A
|
Monkey
|
Kidney
|
Epithelial
| null | 72 | 0.36 |
MTS
|
TetrazoliumSalt
| 41.527 |
10.1016/j.jhazmat.2013.11.031
| 16 | null | null | null |
VERO
|
Journal of Hazardous Materials
|
Elsevier BV
| 2,014 |
Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines
| false |
FALSE
|
closed
|
16_chueh2014.pdf
| 0 |
675 |
Au
|
Rod
| null |
Commercial
| null | null | null | 3,000 |
A
|
Monkey
|
Kidney
|
Epithelial
| null | 72 | 0.72 |
MTS
|
TetrazoliumSalt
| 27.959 |
10.1016/j.jhazmat.2013.11.031
| 16 | null | null | null |
VERO
|
Journal of Hazardous Materials
|
Elsevier BV
| 2,014 |
Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines
| false |
FALSE
|
closed
|
16_chueh2014.pdf
| 0 |
676 |
Au
|
Rod
| null |
Commercial
| null | null | null | 3,000 |
A
|
Monkey
|
Kidney
|
Epithelial
| null | 72 | 1 |
MTS
|
TetrazoliumSalt
| 28.37 |
10.1016/j.jhazmat.2013.11.031
| 16 | null | null | null |
VERO
|
Journal of Hazardous Materials
|
Elsevier BV
| 2,014 |
Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines
| false |
FALSE
|
closed
|
16_chueh2014.pdf
| 0 |
677 |
SiO2
|
Sphere
| null |
Commercial
|
Negative
| 96 | null | 10,000 |
H
|
Human
|
Skin
|
Epithelial
|
Adult
| 72 | 25 |
MTT
|
TetrazoliumSalt
| 88.973 |
10.1177/0960327112459206
| 17 | null | 15 | null |
A431
|
Human & Experimental Toxicology
|
SAGE Publications
| 2,013 |
Silica nanoparticles-induced cytotoxicity, oxidative stress and apoptosis in cultured A431 and A549 cells
| false |
FALSE
|
closed
|
17_ahamed2013.pdf
| 0 |
678 |
SiO2
|
Sphere
| null |
Commercial
|
Negative
| 96 | null | 10,000 |
H
|
Human
|
Skin
|
Epithelial
|
Adult
| 72 | 50 |
MTT
|
TetrazoliumSalt
| 76.933 |
10.1177/0960327112459206
| 17 | null | 15 | null |
A431
|
Human & Experimental Toxicology
|
SAGE Publications
| 2,013 |
Silica nanoparticles-induced cytotoxicity, oxidative stress and apoptosis in cultured A431 and A549 cells
| false |
FALSE
|
closed
|
17_ahamed2013.pdf
| 0 |
679 |
SiO2
|
Sphere
| null |
Commercial
|
Negative
| 96 | null | 10,000 |
H
|
Human
|
Skin
|
Epithelial
|
Adult
| 72 | 100 |
MTT
|
TetrazoliumSalt
| 59.949 |
10.1177/0960327112459206
| 17 | null | 15 | null |
A431
|
Human & Experimental Toxicology
|
SAGE Publications
| 2,013 |
Silica nanoparticles-induced cytotoxicity, oxidative stress and apoptosis in cultured A431 and A549 cells
| false |
FALSE
|
closed
|
17_ahamed2013.pdf
| 0 |
680 |
SiO2
|
Sphere
| null |
Commercial
|
Negative
| 96 | null | 10,000 |
H
|
Human
|
Skin
|
Epithelial
|
Adult
| 72 | 200 |
MTT
|
TetrazoliumSalt
| 48.923 |
10.1177/0960327112459206
| 17 | null | 15 | null |
A431
|
Human & Experimental Toxicology
|
SAGE Publications
| 2,013 |
Silica nanoparticles-induced cytotoxicity, oxidative stress and apoptosis in cultured A431 and A549 cells
| false |
FALSE
|
closed
|
17_ahamed2013.pdf
| 0 |
681 |
SiO2
|
Sphere
| null |
Commercial
|
Negative
| 96 | null | 10,000 |
H
|
Human
|
Lung
|
Epithelial
|
Adult
| 72 | 25 |
MTT
|
TetrazoliumSalt
| 87.072 |
10.1177/0960327112459206
| 17 | null | 15 | null |
A549
|
Human & Experimental Toxicology
|
SAGE Publications
| 2,013 |
Silica nanoparticles-induced cytotoxicity, oxidative stress and apoptosis in cultured A431 and A549 cells
| false |
FALSE
|
closed
|
17_ahamed2013.pdf
| 0 |
682 |
SiO2
|
Sphere
| null |
Commercial
|
Negative
| 96 | null | 10,000 |
H
|
Human
|
Lung
|
Epithelial
|
Adult
| 72 | 50 |
MTT
|
TetrazoliumSalt
| 74.018 |
10.1177/0960327112459206
| 17 | null | 15 | null |
A549
|
Human & Experimental Toxicology
|
SAGE Publications
| 2,013 |
Silica nanoparticles-induced cytotoxicity, oxidative stress and apoptosis in cultured A431 and A549 cells
| false |
FALSE
|
closed
|
17_ahamed2013.pdf
| 0 |
683 |
SiO2
|
Sphere
| null |
Commercial
|
Negative
| 96 | null | 10,000 |
H
|
Human
|
Lung
|
Epithelial
|
Adult
| 72 | 100 |
MTT
|
TetrazoliumSalt
| 58.048 |
10.1177/0960327112459206
| 17 | null | 15 | null |
A549
|
Human & Experimental Toxicology
|
SAGE Publications
| 2,013 |
Silica nanoparticles-induced cytotoxicity, oxidative stress and apoptosis in cultured A431 and A549 cells
| false |
FALSE
|
closed
|
17_ahamed2013.pdf
| 0 |
684 |
SiO2
|
Sphere
| null |
Commercial
|
Negative
| 96 | null | 10,000 |
H
|
Human
|
Lung
|
Epithelial
|
Adult
| 72 | 200 |
MTT
|
TetrazoliumSalt
| 44.994 |
10.1177/0960327112459206
| 17 | null | 15 | null |
A549
|
Human & Experimental Toxicology
|
SAGE Publications
| 2,013 |
Silica nanoparticles-induced cytotoxicity, oxidative stress and apoptosis in cultured A431 and A549 cells
| false |
FALSE
|
closed
|
17_ahamed2013.pdf
| 0 |
685 |
SiO2
|
Sphere
| null |
Commercial
|
Negative
| 96 | -28 | 10,000 |
H
|
Human
|
Liver
|
Epithelial
|
Adult
| 72 | 1 |
MTT
|
TetrazoliumSalt
| 96.842 |
10.1016/j.taap.2011.12.020
| 18 | null | 14.23 | -25 |
HepG2
|
Toxicology and Applied Pharmacology
|
Elsevier BV
| 2,012 |
Apoptosis induction by silica nanoparticles mediated through reactive oxygen species in human liver cell line HepG2
| false |
FALSE
|
closed
|
18_ahmad2012.pdf
| 0 |
686 |
SiO2
|
Sphere
| null |
Commercial
|
Negative
| 96 | -28 | 10,000 |
H
|
Human
|
Liver
|
Epithelial
|
Adult
| 72 | 5 |
MTT
|
TetrazoliumSalt
| 95 |
10.1016/j.taap.2011.12.020
| 18 | null | 14.23 | -25 |
HepG2
|
Toxicology and Applied Pharmacology
|
Elsevier BV
| 2,012 |
Apoptosis induction by silica nanoparticles mediated through reactive oxygen species in human liver cell line HepG2
| false |
FALSE
|
closed
|
18_ahmad2012.pdf
| 0 |
687 |
SiO2
|
Sphere
| null |
Commercial
|
Negative
| 96 | -28 | 10,000 |
H
|
Human
|
Liver
|
Epithelial
|
Adult
| 72 | 10 |
MTT
|
TetrazoliumSalt
| 91.184 |
10.1016/j.taap.2011.12.020
| 18 | null | 14.23 | -25 |
HepG2
|
Toxicology and Applied Pharmacology
|
Elsevier BV
| 2,012 |
Apoptosis induction by silica nanoparticles mediated through reactive oxygen species in human liver cell line HepG2
| false |
FALSE
|
closed
|
18_ahmad2012.pdf
| 0 |
688 |
SiO2
|
Sphere
| null |
Commercial
|
Negative
| 96 | -28 | 10,000 |
H
|
Human
|
Liver
|
Epithelial
|
Adult
| 72 | 25 |
MTT
|
TetrazoliumSalt
| 79.342 |
10.1016/j.taap.2011.12.020
| 18 | null | 14.23 | -25 |
HepG2
|
Toxicology and Applied Pharmacology
|
Elsevier BV
| 2,012 |
Apoptosis induction by silica nanoparticles mediated through reactive oxygen species in human liver cell line HepG2
| false |
FALSE
|
closed
|
18_ahmad2012.pdf
| 0 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.